AIGEN INVESTMENT MANAGEMENT, LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$206,000
-12.7%
6,266
-7.0%
0.04%
-2.4%
Q2 2021$236,000
-18.1%
6,737
-15.4%
0.04%
+7.9%
Q1 2021$288,000
+10.8%
7,961
-11.2%
0.04%
+11.8%
Q4 2020$260,000
+6.1%
8,965
+3.3%
0.03%
+9.7%
Q3 2020$245,000
-38.3%
8,675
-29.4%
0.03%
-39.2%
Q2 2020$397,00012,2790.05%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders